HEalthcarE
Marketing for healthcare organizations
For digital health, health tech, behavioral health, AI-enabled healthcare, and emerging therapeutic categories — organizations operating in regulated, reference driven markets. Built around compliance, clinical credibility, and the trust signals that move buyers in slow moving categories.
What's Different About Healthcare Marketing
Healthcare doesn't behave like consumer or generic B2B. The buyers are slower, the regulatory environment is heavier, the trust signals are different, and the consequences of marketing failure are operationally and clinically real. Most marketing playbooks borrowed from other categories don't translate.
Five things change when you market in or into healthcare:
Compliance shapes everything. HIPAA, FDA promotional rules, state licensure laws, and accrediting body standards constrain what you can claim, how you can prove it, and which channels you can use. Marketing that ignores those constraints either fails to ship or creates legal exposure.
Reference and reputation outperform creative. Buyers in healthcare — clinicians, hospital executives, payer leaders, even patients in serious conditions — are skeptical by training. Peer references, KOL endorsements, accreditation signals, and outcome data move decisions more than aspirational brand work.
Buying decisions are risk-averse and committee-driven. Healthcare leaders are rewarded for avoiding failure more than for pursuing experimentation. That asymmetry shapes every conversation. Marketing that treats novelty as a feature often loses to marketing that treats predictability as a feature.
Trust compounds slowly, but it compounds. Unknown vendors face a significant trust tax in healthcare. Established players keep advantages that aren't immediately obvious. Brand investment here is more durable than in faster-moving categories — but the early ramp is harder.
AI search is now the discovery layer for both clinicians and patients. Physicians use AI engines for clinical research, drug references, and program comparison. Patients increasingly start health research in ChatGPT and Perplexity. Healthcare organizations absent from AI engines are losing visibility at the moment of decision on both sides of the funnel.
Who We Serve
Healthcare is not one market. It is a collection of operating models, buying behaviors, and trust systems. Each segment requires a different growth motion, a different proof structure, and a different path to adoption.
Digital Health — Telehealth, remote monitoring, virtual first care models, consumer health platforms, chronic condition management programs, employer health solutions, behavioral health delivery platforms, and hybrid care systems. This segment spans consumer, employer, payer, and provider facing models. Marketing often runs dual motions with direct patient acquisition on one side and enterprise partnerships on the other. Success depends on engagement, retention, and measurable clinical or cost outcomes — not initial acquisition alone.
Health Tech & Devices — Medical devices, AI diagnostics, clinical workflow platforms, lab and imaging technology. Marketing is reference-driven, KOL anchored, and dependent on clinical evidence, with longer cycles and higher trust bars than typical B2B.
Clinical & Specialty Software — Behavioral health platforms, specialty practice management systems, EHR adjacent tools, care coordination platforms, clinical workflow software, and AI assisted documentation solutions. These organizations operate in environments where clinician trust, workflow fit, reimbursement complexity, and staffing constraints determine adoption. Marketing must speak across executives, clinical leaders, and frontline users who decide whether a product reduces friction or adds it. For SaaS-specific buying-committee and ABM mechanics, see our Healthcare B2B SaaS practice.
AI-Enabled Healthcare — Workforce intelligence platforms, operational optimization tools, predictive analytics, care management infrastructure, and clinical decision support technologies. These companies sell into organizations that expect measurable operational outcomes, defensible data models, and credible implementation pathways. Marketing is often consensus-driven across operations, finance, IT, compliance, and executive leadership. Trust depends less on awareness and more on evidence, integration capability, and confidence in scalability.
Regenerative & Investigational — Regenerative medicine clinics, investigational treatment providers, expanded access programs, longevity focused care models, and emerging therapeutic categories. These organizations operate under elevated scrutiny where scientific credibility, regulatory precision, patient education, and ethical communication are central. Trust is built through physician authority, transparent communication, published evidence, and careful expectation-setting.
The Three Buyer Contexts in Healthcare
Healthcare marketing is rarely a single motion. Most companies in this segment operate across two or three of these buyer contexts simultaneously — and each requires its own engine.
B2C — Patients, Members, and Consumers
Patients researching conditions, members choosing care programs, consumers comparing digital health tools, and individuals exploring regenerative or longevity options. The buyer is making a decision under uncertainty, often with emotional weight, and often after starting research in an AI engine. Marketing wins here on clear, trustworthy information, outcomes evidence, accessibility, and reputation. Aspirational creative underperforms compliance-anchored clarity.
B2B — Selling to Health Systems, Payers, Employers, or Specialty Practices
Most companies in this segment sell into enterprise buyers — health systems, payer organizations, employer benefits teams, or specialty practices. Long cycles, committee buying, formal procurement, security and compliance gating. Marketing here is account-based, reference-led, and trust-anchored — not high-velocity demand generation. The buying committee usually involves clinical, financial, compliance, and IT stakeholders, each evaluating different risks.
B2B2C — Enterprise Sale + End-User Adoption
An intermediary motion: the buyer is enterprise (employer, payer, health system, or specialty practice), but the end users are the people actually using the product day to day — most often clinicians (nurses, therapists, physicians, frontline staff) inside clinical software, AI documentation, and workflow tools, or members, employees, and patients inside consumer-facing digital health programs. Marketing has to satisfy two audiences with very different criteria — the enterprise buyer cares about ROI, integration, and compliance; the end user cares about workflow fit, ease of use, trust, and outcomes. Most companies under-invest in the second audience and the program stalls in adoption even after the contract is signed.
Why this matters
Each context requires a different go-to-market strategy.
B2C demand is awareness and trust driven. B2B demand is reference and relationship driven. B2B2C demand requires both — enterprise sales motions paired with end-user adoption marketing, whether the end user is a clinician inside a workflow, a patient inside a care program, or a member inside a benefits plan.
Companies that succeed across two or three contexts usually succeed because they treat them as separate but coordinated engines, not one funnel. Companies that struggle often have one over-developed engine and one or two underbuilt ones.
How Our Capabilities Apply Here
The three capabilities we bring to every engagement — adapted for the specifics of healthcare's compliance, trust, and committee dynamics.
Marketing & GTM Strategy
Buyer-context mapping (B2C, B2B, B2B2C), compliance-anchored positioning, KOL and reference network development, enterprise sales enablement, and segmented messaging tracks for each stakeholder. For digital health and behavioral health companies, this includes dual-funnel design where the enterprise buyer and the end user (clinician, patient, or member) require separately tuned marketing motions.
Digital Transformation & Modernization
Martech rationalization for organizations operating under HIPAA, BAA constraints, and EHR integration requirements. Lifecycle marketing for long buying cycles and slow end-user adoption curves. Reputation management infrastructure tied to clinical outcomes data. Modernization sequencing for legacy marketing functions inside digital health, health tech, and behavioral health companies.
AEO & AI Search Visibility
Clinicians, patients, and procurement teams are increasingly starting healthcare research in AI engines. We make your organization the source AI engines surface when patients ask about conditions, when clinicians compare programs, and when employers evaluate benefits vendors. Learn more about our AEO services →
Common Miscalculations
Assuming consumer marketing playbooks translate
Healthcare is not e-commerce. Most decisions involve emotional weight, regulatory framing, and reference behavior that consumer-tested playbooks (DTC funnels, performance marketing, aggressive A/B testing) don't handle well. Healthcare buyers often respond worse to urgency tactics and better to evidence and patience than the same buyers would in other consumer categories.
Underestimating compliance friction
HIPAA, FDA promotional rules, state regulations, accreditation standards, and corporate compliance reviews can slow campaigns from weeks to months. Vendors that don't build compliance into the marketing process from day one create downstream pain — for themselves, their clients, and the buyer organizations.
Mistaking reach for reputation
Awareness without trust is empty in healthcare. Spending heavily on impressions before building reference networks, KOL relationships, and clinical evidence produces visibility without conversion. Reputation has to be built before reach scales.
Treating KOLs as influencers
Healthcare KOLs are not consumer influencers. The relationship is longer, deeper, and built on clinical alignment — not transactional sponsorship. Programs that treat KOLs like brand ambassadors usually fail. Programs that treat them as long term clinical partners often outperform paid media.
Building one engine for multi-context healthcare
Most healthcare organizations operate across B2C, B2B, and B2B2C simultaneously. A single marketing team running a single funnel typically over invests in one context and under invests in the others. The strongest healthcare marketing organizations build coordinated but distinct engines for each context.
Representative Outcomes
Across engagements with digital health, health tech, behavioral health, AI-enabled healthcare, and regenerative care companies, the work has included:
Aligned commercial, clinical, and marketing teams around shared outcomes — patient acquisition, enterprise partnerships, clinical adoption
Rebuilt demand and reputation engines tuned to compliance, accreditation, and KOL signals
Repositioned brands, value propositions, and clinical messaging for regulated, reference-driven categories
Strengthened patient experience, member retention, and end-user adoption inside enterprise contracts
Built separate but coordinated engines for B2C, B2B, and B2B2C marketing motions inside one healthcare organization
Supported M&A, integrations, and post-acquisition GTM transitions
Frequently Asked Questions
-
Digital Health (telehealth, remote monitoring, consumer health, hybrid care), Health Tech & Devices (medical devices, AI diagnostics, clinical workflow), Clinical & Specialty Software (behavioral health, specialty practice management, EHR-adjacent tools, AI documentation), AI-Enabled Healthcare (workforce intelligence, predictive analytics, clinical decision support), and Regenerative & Investigational (regenerative medicine, investigational treatments, longevity-focused care). We work with organizations from founder-led startups through established mid-market and enterprise companies.
-
Five things: compliance constraints (HIPAA, FDA, state regs) shape every campaign; reference and reputation outperform creative; buying decisions are risk averse and committee driven; trust compounds slowly but durably; and AI search is now the discovery layer for both clinicians and patients. Most marketing playbooks borrowed from consumer or generic B2B don't translate.
-
B2C — patients and members making personal decisions about care, plans, or digital health tools. B2B — selling to health systems, payer organizations, employer benefits teams, or specialty practices. B2B2C — the intermediary motion where the buyer is enterprise (employer, payer, health system) but the end user is the person actually using the product day to day, most often a clinician inside a workflow or a member/patient inside a care program. Each context requires a different go-to-market strategy.
-
Compliance is built into the work from day one, not bolted on at the end. We coordinate with your legal, regulatory, and compliance teams before campaigns ship — not after. For digital health and behavioral health companies, that includes HIPAA aligned content development. For health tech and device companies, FDA promotional review processes are baked into content calendars. For regenerative and investigational care, that includes careful expectation setting and FDA aware claims management.
-
KOLs (Key Opinion Leaders — physicians, clinical specialists, research leaders, Nursing Leadership) are clinical partners, not consumer influencers. The relationship is long term, evidence based, and built on aligned clinical interests. Programs that treat KOLs like brand ambassadors usually fail. Programs that treat them as long term partners often outperform paid media. We design KOL strategy as an authority discipline, not a sponsorship discipline.
-
Both clinicians and patients are increasingly starting healthcare research in AI engines. Physicians use them for clinical references and program comparison. Patients use them for condition research, treatment options, and provider recommendations. Healthcare organizations absent from AI citation surfaces are losing visibility at the moment of decision — on both the clinical and consumer sides of the funnel. AEO work for healthcare is high leverage because the trust signals AI engines weight (clinical evidence, peer references, accreditation, structured data) overlap heavily with what healthcare buyers already trust.
-
Yes. Engagements scope to stage and category. Early stage digital health and behavioral health startups typically need GTM strategy, dual-funnel design, and channel buildout. Mid-market and established health tech, AI enabled healthcare, and regenerative care companies more often need modernization, reputation architecture, and AEO for category authority. The methodology adapts. The deliverables shift to match where you are and what you sell.
Ready to build healthcare marketing that respects the buyer?
Considering a GTM rebuild for a digital health product, a marketing modernization for a clinical software company, a reputation and KOL strategy for a health tech or device company, or an AEO audit tied to your category authority? Book a 20-minute working session. No deck, no pitch — bring one specific problem, leave with one concrete next step.